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Abstract
Carbapenem resistance is increasingly being reported among Acinetobacter species, and results mostly from the expression of acquired
carbapenem-hydrolysing oxacillinases (CHDLs). Several Acinetobacter species intrinsically possess chromosomal CHDL genes: Acinetobac-
ter baumannii (blaOXA-51), Acinetobacter radioresistens (blaOXA-23), and Acinetobacter lwofﬁi (blaOXA-134). We aimed to identify the progeni-
tors of novel CHDL-encoding genes for identiﬁcation of potential reservoirs. We performed PCR screening using degenerated internal
primers designed from a sequence alignment of the known CHDLs (OXA-23, OXA-40, OXA-51, OXA-58, OXA-134, and OXA-143)
applied to a collection of 50 Acinetobacter strains belonging to 23 different species. Two strains of Acinetobacter johnsonii, one strain of
Acinetobacter calcoaceticus and two strains of Acinetobacter haemolyticus were found to harbour, respectively, the totally novel blaOXA-211-
like, blaOXA-213-like and blaOXA-214-like genes. In addition, the complete genomes of those three species available in GenBank, i.e. one
A. johnsonii genome, four A. calcoaceticus genomes, and one A. haemolyticus genome, were analysed and found to be positive for the pres-
ence of blaOXA211-like, blaOXA-213-like and blaOXA-214-like genes, respectively. The b-lactamases OXA-211, OXA-213 and OXA-214 are
diverse, with amino acid identities ranging from 53% to 76%, as compared with the naturally occurring OXA-51-like CHDL from A. bau-
mannii. These b-lactamases showed a peculiar hydrolysis proﬁle, including mostly penicillins and carbapenems. Regarding blaOXA-23 in
A. radioresistens and blaOXA-134 in A. lwofﬁi, these genes were not expressed (or expressed at a non-signiﬁcant level) in their host. Detec-
tion of these b-lactamase genes might be used as a useful tool for accurate identiﬁcation of these Acinetobacter species.
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Introduction
Although Acinetobacter baumannii is considered to be the most
clinically relevant Acinetobacter species, there are increasing
reports of community and nosocomial infections caused by
non-baumannii Acinetobacter species [1]. This is probably a con-
sequence of the development of genetic tools for identiﬁcation
of the different Acinetobacter species. Acinetobacter haemolyticus
was found to be a causative agent of endocarditis [2] and
bloody diarrhoea mediated by Shiga toxin production [3].
Acinetobacter johnsonii was found to be associated with
catheter-related bloodstream infections [4]. As there is a close
relationship between A. baumannii and Acinetobacter calcoaceti-
cus, the term A. baumannii–A. calcoaceticus complex, or Abc
complex, has been used, and the exact clinical relevance of
A. calcoaceticus therefore remains unclear [5]. Although antimi-
crobial susceptibility in all other Acinetobacter species is usually
much higher than in A. baumannii, antimicrobial resistance in
non-baumannii Acinetobacter species raises concern, as multi-
drug-resistant isolates, including carbapenem-resistant isolates,
are being reported worldwide [6,7]. Furthermore, some
ª2011 The Authors
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE BACTERIOLOGY
Acinetobacter species have been shown to intrinsically possess
chromosomal genes encoding carbapenem-hydrolysing
oxacillinases (CHDLs). Thus, A. baumannii carries blaOXA-51-
like, Acinetobacter radioresistens blaOXA-23-like and Acinetobacter
lwofﬁi blaOXA-134-like genes [8–10]. Characterization of these
naturally occurring CHDL-encoding genes seems important
for two reasons. First, these genes may spread into other Aci-
netobacter species, such as A. baumannii, causing outbreaks of
carbapenem-resistant strains, as has been reported with
blaOXA-23-carrying A. baumannii isolates [11]. Second, detec-
tion of these b-lactamase genes might be used as an additional
tool for rapid identiﬁcation of Acinetobacter species.
Materials and Methods
Bacterial strains
A. haemolyticus VAL was recovered from a clinical sample.
A. calcoaceticus CIP81.8 and A. johnsonii CIP70.16 were pur-
chased from the Institut Pasteur collection. A. baumannii AYE
and A. radioresistens strain 2 were recovered from clinical
samples [10]. Our screening panel included Acinetobacter
strains belonging to 23 different Acinetobacter species, including
Acinetobacter junii, A. johnsonii, A. haemolyticus, Acinetobacter
baylyi, A. lwofﬁi, A. radioresistens, Acinetobacter schindleri, Acineto-
bacter ursingii, A. calcoaceticus, Acinetobacter gerneri, Acinetobacter
tjernbergiae, Acinetobacter bouvetii, Acinetobacter tandoii, Acineto-
bacter grimontii, Acinetobacter towneri, Acinetobacter parvus, Aci-
netobacter pittii sp. nov. (formerly Acinetobacter genomic
species 3), Acinetobacter nosocomialis sp. nov. (formerly Acineto-
bacter genomic species 13TU) [12], Acinetobacter bereziniae
sp. nov. (formerly Acinetobacter genomic species 10) [13], and
Acinetobacter genomospecies 6, 15, 16, and 17. These strains
were identiﬁed at the species level with the use of 16S rRNA
sequencing [14].
Antimicrobial agents and MIC determinations
The antimicrobial agents and their sources have been
described previously [14]. Antibiotic-containing disks were
used for detection of antibiotic susceptibility, with Mueller–
Hinton agar plates (Sanoﬁ Diagnostics Pasteur, Marnes-
La-Coquette, France) and a disk diffusion assay (http://
www.sfm.fr). MICs were determined by agar dilution and
Etest (AB Biodisk, Solna, Sweden) [15], with results inter-
preted according to the guidelines of the CLSI [16].
PCR ampliﬁcation and cloning experiments
Whole cell DNA of Acinetobacter species was extracted as
described previously [10]. PCRs were performed in standard
conditions with Taq DNA polymerase (Applied Biosystems,
Courtaboeuf, France), as described previously [10]. Screening
for CHDL-encoding genes was performed by PCR with the
degenerate internal primers OXA-CHDL A and OXA-
CHDL B (Table 1). Degenerate internal primers were
designed in the corresponding nucleotide regions of conserved
protein sequences after complete OXA-23, OXA-40, OXA-
58, OXA-51, OXA-134 and OXA-143 protein sequence
alignment. Complete available genome sequences of A. haemo-
lyticus ATCC 19194 (GenBank accession number NZ_
ADMT00000000.1), A. johnsonii SH046 (Genbank accession
number ACPL01000000) and A. calcoaceticus RUH2202 (Gen-
Bank accession number ZP_06056651.1) were screened in
order to determine genomic sequences ﬂanking the internal
fragments of the novel genes temporarily named blaOXA-H,
blaOXA-J, and blaOXA-C, respectively. External primers speciﬁc
for each gene were designed and used for PCR, allowing ampli-
ﬁcation of the entire sequences of these genes (Table 1).
OXA-calcoaceticus A-B, OXA-haemolyticus A-B and OXA-
johnsonii A-B (Table 1) were used to amplify fragments con-
taining the entire oxacillinase-encoding gene, with whole cell
DNA from A. calcoaceticus, A. haemolyticus and A. johnsonii as
the template.
The obtained PCR fragment was puriﬁed with a QIAquick
column (Qiagen, Courtaboeuf, France) and cloned into the
pTOPO vector. Recombinant plasmids were selected on try-
pticase soy agar plates containing amoxycillin (25 mg/mL) and
kanamycin (30 mg/mL). The cloned DNA fragments inserted
into one of the recombinant plasmids were sequenced each
TABLE 1. Primers used in this study
Primers Sequence (5¢ to 3¢) Purpose
Expected
amplicon
size (bp)
OXA-CHDL A CCHGCHTCDACHTTYAARAT Detection of CHDL 485
OXA-CHDL B KYHAYABCCMWKSCCCADCC
OXA-calcoaceticus A ACCGCCATATCAACTTTCC Detection and ampliﬁcation of natural CHDL of Acinetobacter calcoaceticus 1028
OXA-calcoaceticus B TTGAGCACACCATTTCATCC
OXA-haemolyticus A TTTTCTAGCTCGGCTTTCCCC Detection and ampliﬁcation of natural CHDL of Acinetobacter haemolyticus 1075
OXA-haemolyticus B ATCCCTCTAGGATGATTTCTCCC
OXA-johnsonii A TTTAGATCTTAGCCACCC Detection and ampliﬁcation of natural CHDL of Acinetobacter johnsonii 863
OXA-johnsonii B AATACGTCTTCTCTATGGGC
CHDL, carbapenem-hydrolysing oxacillinase.
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time from two clones on both strands with an Applied Bio-
systems sequencer (ABI 377).
b-Lactamase preparation and biochemical analysis
Cultures of Escherichia coli expressing blaOXA-211, blaOXA-213
and blaOXA-214 were grown overnight at 37C in 100 mL of
trypticase soy broth with amoxycillin (25 mg/L). Bacterial
suspensions were disrupted by sonication (twice for 30 s
each time at 20 Hz (Phospholyser Vibra Cell 300; Bioblock,
Illkirch, France)) and centrifuged (10 min, 10 000 g, 4C).
The supernatants contained the crude enzyme extracts.
Crude enzyme extracts containing partially puriﬁed b-lacta-
mases were subjected to speciﬁc activity measurements. The
b-lactamase activities of E. coli TOP10 cultures harbouring
pOXA-211, pOXA-213 and pOXA-214 were assayed by UV
spectrophotometry (Spectrophotometer Ultrospec 2000;
Pharmacia Biotech, Orsay, France) at 30C in 100 mM phos-
phate buffer (pH 7.0), as previously described [17].
Dendrogram and protein analysis
The nucleotide and deduced amino acid sequences were ana-
lyzed and compared with sequences available over the Inter-
net at the National Center for Biotechnology Information
website (http://www.ncbi.nlm.nih.gov/BLAST/).
Results and Discussion
Screening of CHDL-encoding genes in a collection of Acinet-
obacter species.
PCR screening with degenerate internal primers gave posi-
tive results for A. baumannii, A. radioresistens, A. lwofﬁi, A. hae-
molyticus, A. johnsonii, and A. calcoaceticus. After sequencing,
A. baumannii, A. radioresistens and A. lwofﬁi were found to pos-
sess the blaOXA-51, blaOXA-23 and blaOXA-134 genes, respec-
tively, in accordance with previous results [8–10]. PCR
screening with these degenerate internal primers gave weak
FIG. 1. Amino acid alignment of b-lactamases OXA-211, OXA-213 and OXA-214 identiﬁed in this study from Acinetobacter johnsonii, Acinetobac-
ter calcoaceticus, and Acinetobacter haemolyticus, respectively. Amino acid motifs that are well conserved (even if possibly variable) among class D
b-lactamases (DBLs) are shaded in grey [19]. Numbering is according to DBL numbering [16]. Asterisks indicate identical amino acids between
all sequences.
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bands for the following isolates: A. bouvettii, A. parvus, A. pittii
sp. nov., A. nosocomialis sp. nov., A. bereziniae sp. nov.,
Acinetobacter genomic species 6, and Acinetobacter genomic
species 17. The corresponding sequences were relatively far
from the sequences of the known CHDL-encoding genes
from Acinetobacter species: blaOXA-23, blaOXA-40, blaOXA-51,
blaOXA-58, and blaOXA-134 (data not shown). Thus, these
weakly positive PCR results were not further investigated.
PCR screening was negative for A. junii, A. baylyi, A. schindleri,
A. ursingii, A. gerneri, A. tjernbergiae, A. tandoii, A. grimontii, and
A. towneri.
Sequencing of CHDL-encoding genes
Sequencing of the amplicons obtained from A. haemolyticus,
A. johnsonii and A. calcoaceticus identiﬁed three genes encod-
ing novel OXA-type b-lactamases. OXA-H was named
OXA-214, and shared 53% amino acid identity with OXA-
23, 55% with OXA-51, 53% with OXA-40, and 48% with
OXA-58. OXA-J was named OXA-211, and shared 55%
amino acid identity with OXA-23, 58% with OXA-51, 56%
with OXA-40, and 52% with OXA-58. OXA-C was named
OXA-213, and shared 57% amino acid identity with OXA-
23, 76% with OXA-51, 62% with OXA-40, and 46% with
OXA-58.
OXA-211, OXA-213 and OXA-214 possessed the typical
features of class D b-lactamases (DBLs), including the STFK
tetrad at positions 70–73 according to DBL numbering
(Fig. 1) [16]. Also, in OXA-213 and OXA-214, an FGN motif
at DBL positions 144–146 replaced the usual YGN motif of
classical DBLs, as observed for other CHDLs except for
OXA-58, OXA-51, and OXA-211 [17]. Finally, a KSG ele-
ment was identiﬁed at DBL positions 216–218, as observed
in the CHDLs OXA-40 and OXA-51, whereas a KTG motif
is present in most DBLs, including the CHDL OXA-23 [17].
A phylogenetic analysis showed that OXA-211, OXA-213
and OXA-214 constituted separate subgroups of CHDLs,
but that these subgroups were more closely related to the
identiﬁed DBLs from Acinetobacter species than to other
known CHDLs (Fig. 2).
Susceptibility patterns
All of the A. haemolyticus VAL, A. johnsonii CIP70.16, A. calco-
aceticus CIP81.8 and A. radioresistens strain 2 isolates were
fully susceptible to all antibiotics tested, including penicillins
and carbapenems (Table 2). A. baumannii AYE was only sus-
ceptible to carbapenems, because it carried the extended-
spectrum b-lactamase VEB-1 and overexpressed the ampC
gene, as previously described [18].
Distribution of OXA-211, OXA-213 and OXA-214 CHDL-
encoding genes
In order to assess whether the novel OXA-encoding genes
were naturally present in the Acinetobacter species, the
blaOXA-211, blaOXA-213 and blaOXA-214 genes were screened
FIG. 2. Dendrogram obtained for 23 class D b-lactamases by neighbour-joining analysis. The alignment used for tree calculation was performed
with ClustalX. Branch lengths are drawn to scale, and are proportional to the number of amino acid changes. The distance along the vertical axis
has no signiﬁcance. The class D b-lactamases that are considered to be naturally occurring are indicated, together with the names of the corre-
sponding species.
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out in additional clinical isolates of A. johnsonii, A. calcoaceti-
cus, and A. haemolyticus, respectively. PCR with speciﬁc prim-
ers was performed, and gave positive results for the blaOXA-
214 gene in the two A. haemolyticus isolates tested, for the
blaOXA-211 gene in the two A. johnsonii isolates tested, and
for the blaOXA-213 gene in the one A. calcoaceticus isolate
tested.
In addition, the blaOXA-211, blaOXA-213 and blaOXA-214 genes
were screened out in all complete genomes of these three
species available on Genbank. The blaOXA-211 gene was iden-
tiﬁed in one A. johnsonii genome (GenBank accession number
ACPL01000000), the blaOXA-214 gene was identiﬁed in one
A. haemolyticus genome (GenBank accession number NZ_
ADMT00000000.1), and the blaOXA-213 gene was identiﬁed in
four A. calcoaceticus genomes (A. calcoaceticus RUH2202,
GenBank accession number ZP_06056651.1; A. calcoaceti-
cus DR1, GenBank accession number CP002080.1; A calco-
aceticus PHEA-2, GenBank accession number CP002177.1;
and Acinetobacter sp. SH024, GenBank accession number
ZP_06690603.1).
Thus, screening of clinical isolates and analysis of the avail-
able complete genomes for each species allowed identiﬁ-
cation of a total of three variants of OXA-214 from
A. haemolyticus, three variants of OXA-211 from A. johnsonii,
and ﬁve variants of OXA-213 from A. calcoaceticus.
Biochemical properties of OXA-211, OXA-213, OXA-214
To further characterize the activity of OXA-211, OXA-213
and OXA-214, the enzymes were puriﬁed from E. coli
cultures containing recombinant plasmid expressing these
CHDLs, as described previously [17]. OXA-211, OXA-213
and OXA-214 showed a peculiar hydrolysis proﬁle. These
enzymes were able to hydrolyse penicillins and carbapenems.
However, as observed for most of the CHDLs, broad-spec-
trum cephalosporins and monobactams were spared [20].
The rates of carbapenem hydrolysis were similar to those of
OXA-23 and OXA-51 (Table 3).
Genetic context of OXA-211, OXA-213 and OXA-214
CHDL-encoding genes
In silico analysis of whole genome sequences of A. johnsonii,
A. haemolyticus and A. calcoaceticus led to the identiﬁcation of
genes surrounding these CHDL-encoding genes. These genes
were chromosomally located. Upstream of the blaOXA-211 gene
from A. johnsonii, the dnaK gene was identiﬁed, encoding a
molecular chaperone that modulates the heat shock response
in E. coli. Downstream of the blaOXA-211 gene, there was a
hypothetical open reading frame followed by a matrixin super-
family protein-encoding gene. Upstream of the blaOXA-213
gene from A. calcoaceticus, a gene encoding a putative phage T
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protein was identiﬁed, whereas a sortase family protein-
encoding gene was identiﬁed downstream. Upstream of the
blaOXA-214 gene from A. haemolyticus, a gene encoding an outer
membrane protein was identiﬁed, and a GGDEF family pro-
tein-encoding gene was identiﬁed downstream. This latter
conﬁguration has already been observed for the blaOXA-23
gene from A. radioresistens, which was identiﬁed upstream of
an AAA ATPase family protein-encoding gene [10].
In conclusion, this study identiﬁed naturally occurring
CHDL-encoding genes in A. haemolyticus, A. johnsonii, and
A. calcoaceticus. None of them corresponded to the acquired
CHDL-encoding genes reported in A. baumannii or in any
other Gram-negative rods. As these genes remained highly
speciﬁc to these species, detection of these genes might be
used as an additional tool for rapid identiﬁcation of these Aci-
netobacter species. Finally, this work further indicates that Aci-
netobacter species are the reservoirs of peculiar b-lactamase
genes, actually CHDL genes, whose distribution seems to be
restricted to Gram-negative rods (Pseudomonas, Aeromonas,
etc.). Their natural function remains to be identiﬁed.
Nucleotide sequence accession numbers
The nucleotide sequences of the blaOXA-211, blaOXA-212,
blaOXA-213, blaOXA-214 and blaOXA-215 genes reported in this
article are available in the GenBank nucleotide database
under the following accession numbers: JN861779 for OXA-
211; JN861780 for OXA-212; JN861781 for OXA-213;
JN861782 for OXA-214; and JN861783 for OXA-215.
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